- "Gilead Sciences"
- Registration projects in health and health care
Registration projects in health and health care
The reimbursement conditions for 6 specific types of antiviral hepatitis C medication for the treatment of chronic hepatitis C patients will be extended and 2 new ones will be added. This extended reimbursement will be active starting from 1.1.2017 and is agreed upon for a period of 2 years between RIZIV-INAMI and the 5 involved pharmaceutical companies via a contract of type Art.81 signed with the RIZIV-INAMI..
The hepatitis C antiviral medication is on the list of Chapter 4 medication, which requires the treating physician to fill out a...